ABA-101 in Participants With Progressive Multiple Sclerosis
ABA-101 in Participants With Progressive Multiple Sclerosis
Active, not recruiting · NCT06566261 · Registry updated 2025-07-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ABA-101 in Participants With Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 1 | 2025-07-03 | NCT06566261 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abata Therapeutics | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic Mellen Center | Cleveland | United States | 2 |
| Johns Hopkins University | Baltimore | United States | 150 |
| Rutgers, Robert Wood Johnson Medical School | New Brunswick | United States | 6 |